Girao Tiago — SEC Form 4 filings

SEC reporting owner CIK 1618670. 6 Form 4 filings on record with FilingPulse; latest filed 2026-07-24.

Transaction summary — filings shown

Covers all 6 filings on record, filed 2024-05-23 to 2026-07-24. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Immunovant, Inc. (IMVT)Chief Financial Officer53 legs · 42,558 sh · $1,410,6266
Landos Biopharma, Inc. (LABP)Director13

Form 4 filings — Girao Tiago

FiledFormIssuerReported transactionsSource
2026-07-244Immunovant, Inc. (IMVT)Sale (S): 6,798 @ $38.69EDGAR
2026-06-264Immunovant, Inc. (IMVT)Option exercise (M): 10,000 @ $15.90 · Sale (S): 10,000 @ $38.46 · Option exercise (M): 10,000 (derivative) @ $0EDGAR
2026-04-244Immunovant, Inc. (IMVT)Sale (S): 25,760 @ $29.62EDGAR
2026-04-094Immunovant, Inc. (IMVT)Grant/award (A): 64,968 @ $0 · Grant/award (A): 94,002 (derivative) @ $0EDGAR
2025-05-054Immunovant, Inc. (IMVT)Grant/award (A): 208,388 @ $0 · Grant/award (A): 293,505 (derivative) @ $0EDGAR
2024-05-234Landos Biopharma, Inc. (LABP)Disposition to issuer (D): 1,800 (derivative) · Disposition to issuer (D): 1,800 (derivative) · Disposition to issuer (D): 1,800 (derivative)EDGAR

FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1618670 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →